Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 91-100 of 9365

Page
per page
  1. CX-4945 (Silmitasertib)
    A8330 CX-4945 (Silmitasertib)
     13 Citation
    Summary: CK2 inhibitor
      ≥103.5 mg/mL
  2. Cyclopamine
    A8340 Cyclopamine
     6 Citation
    Target: Smoothened
    Summary: Hedgehog (Hh) signaling Inhibitor
      insoluble in EtOH; insoluble in H2O; ≥6.86 mg/mL
  3. EPZ5676
    A4166 EPZ5676
     2 Citation
    Target: DOT1L
    Summary: DOT1L inhibitor,potent and SAM competitive
      ≥28.15 mg/mL
  4. BMS-911543
    A4152 BMS-911543
    Target: JAK
    Summary: JAK2 inhibitor,selective small molecule
      ≥43.3 mg/mL
  5. Rosiglitazone
    A4304 Rosiglitazone
     4 Citation
    Summary: Potent PPARγ agonist
      insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL
  6. Leupeptin, Microbial
    A2570 Leupeptin, Microbial
     5 Citation
    Target: Cathepsins|Calpains|Trypsins
    Summary: serine and cysteine proteases inhibitor
      ≥24.7 mg/mL
  7. Pepstatin A
    A2571 Pepstatin A
     9 Citation
    Target: Cathepsins|Renin|HIV proteases|Pepsins
    Summary: aspartic proteases inhibitor
      ≥34.3 mg/mL
  8. Afatinib
    A4746 Afatinib
     2 Citation
    Summary: A covalent inhibitor targeting members of the ErbB family
      ≥49.3 mg/mL
  9. 18α-Glycyrrhetinic acid
    A4749 18α-Glycyrrhetinic acid
      Soluble in DMSO
  10. Flucytosine
    A8433 Flucytosine
    Summary: Antifungal drug
      insoluble in EtOH; ≥18.8 mg/mL

Items 91-100 of 9365

Page
per page